-
prevention of
macrovascular events in
patients with type 2
diabetes in the
PROactive Study (PROspective
pioglitAzone Clinical Trial In
macroVascular Events):...
-
Macrovascular disease is a
disease of any
large (
macro)
blood vessels in the body. It is a
disease of the
large blood vessels,
including the
coronary arteries...
- concentration, it also
incurs collateral damage to organs.
Microvascular and
macrovascular complications include nephropathy, retinopathy, neuropathy, and ASCVD...
-
while cardiovascular disease, stroke, and
peripheral vascular disease are
included in the
macrovascular complications. The
complications of
diabetes can dramatically...
-
platelets to
become larger clots,
which leads to
microvascular and
macrovascular thrombosis. This
lodging of
clots in the microcirculation, in the large...
- (diabetic retinopathy,
diabetic nephropathy,
diabetic neuropathy, and
macrovascular disease)
decreased by
about 3% for
every 1 mmol/mol
decrease in HbA1c...
-
Skene A (July 2004). "The
prospective pioglitazone clinical trial in
macrovascular events (PROactive): can
pioglitazone reduce cardiovascular events in...
- 2007). "Effects of a
fixed combination of
perindopril and
indapamide on
macrovascular and
microvascular outcomes in
patients with type 2
diabetes mellitus...
-
Duckworth WC, et al. (November 2009). "Intensive
glucose control and
macrovascular outcomes in type 2 diabetes". Diabetologia. 52 (11): 2288–98. doi:10...
-
Glycation is the non-enzymatic
process responsible for many (e.g.
micro and
macrovascular)
complications in
diabetes mellitus and is
implicated in some diseases...
